Cardiac resynchronisation therapy optimisation of interventricular delay by the systolic dyssynchrony index: A

Jiri Vondrak1, Dan Marek2, Jan Vecera3

  • 1Department of Cardiology, Pardubice Regional Hospital a.s., Pardubice, Czech Republic.

Insights

Optimizing cardiac resynchronization therapy (CRT) interventricular delay using systolic dyssynchrony index (SDI) showed no significant difference compared to QRS width for improving heart function. Both methods yielded similar volumetric and clinical outcomes at 12 months.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Heart Failure Management

Background:

  • Cardiac resynchronization therapy (CRT) is used to treat heart failure patients with electrical dyssynchrony.
  • Optimizing the interventricular (VV) delay in CRT is crucial for maximizing therapeutic benefits.
  • Current methods for VV delay optimization include QRS width assessment and more advanced echocardiographic measures.

Purpose of the Study:

  • To compare the effectiveness of VV delay optimization based on systolic dyssynchrony index (SDI) derived from 3D echocardiography (3DE) versus standard QRS width assessment.
  • To evaluate the impact of these optimization strategies on left ventricle volume reduction at 12-month follow-up in CRT recipients.

Main Methods:

  • A randomized, open-label trial included 63 patients recently implanted with CRT.
  • Patients were assigned to either QRS width optimization (Group 1, n=31) or SDI optimization (Group 2, n=32).
  • Left ventricular end-systolic volume (LVESv), ejection fraction (LVEF), and SDI were assessed using 3DE before implantation and at 12-month follow-up. Clinical outcomes were also evaluated.

Main Results:

  • No significant difference was observed in the number of volumetric responders between the SDI group and the QRS width group (20 vs. 17, P=0.786).
  • Both groups showed similar reductions in LVESv (-61 ± 51 mL vs. -41 ± 55 mL, P=0.111) and improvements in LVEF (+13.0 ± 9.9% vs. +10.1 ± 10.6%, P=0.213).
  • Clinical outcomes, including New York Heart Association functional class, 6-minute walk test, quality of life, and NT-proBNP levels, were comparable between the two groups at 12 months.

Conclusions:

  • Optimization of interventricular delay in CRT using SDI derived from 3DE did not demonstrate a significant advantage over QRS width assessment.
  • Both methods resulted in similar volumetric and clinical responses at the 12-month follow-up.
  • These findings suggest that standard QRS width assessment may be sufficient for VV delay optimization in CRT recipients.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
608
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
493
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
509
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
309